Evidence map›Paper›PMID 42608484›Full record

Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026

Falls in older patients treated for cancer in French outpatient departments: screening and prevention-a prospective observational study.

Romain Levard, Océane Mesnilgrante, Priscille Le Bon, Poppy Evenden, Jean-Matthieu L'Orphelin, Soazig Lebaube, Maud Villemin, Elise Delarue, Angélique Dumont, Samira Basti and 15 more

Registry-linked trialAbstract readObservational StudyMulticenter Study
In one paragraph

Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06504628 (CHUtes Chez Les Personnes Agées traitées Pour Cancer Dans Les HOpitaUx Normands), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06504628 completednot on this map

CHUtes Chez Les Personnes Agées traitées Pour Cancer Dans Les HOpitaUx Normands : repérage et Prévention

TypeobservationalSponsorUniversity Hospital, CaenRan2024 to 2025Enrolled328ConditionsAged Patients Treated for Cancer in OutclinicsArmsscreening risk for falling and identifiy the risk level low-intermediate-high, 3 mnth-follow-up
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Romain LevardCentre de Lutte Contre Le Cancer François Baclesse, UNICANCER, 3 Avenue du Général Harris, 14000, Caen, France. r.levard@baclesse.unicancer.fr.
Océane MesnilgranteCentre Hospitalier Universitaire de Caen Normandie, Caen, France.
Priscille Le BonCentre de Lutte Contre Le Cancer François Baclesse, UNICANCER, 3 Avenue du Général Harris, 14000, Caen, France.
Poppy EvendenUnité de Coordination en OncoGériatrie, Réseau OncoNormandie, Caen, France.
Jean-Matthieu L'OrphelinCentre Hospitalier Universitaire de Caen Normandie, Caen, France.
Soazig LebaubeCentre Hospitalier Universitaire de Caen Normandie, Caen, France.
Maud VilleminPolyclinique du Parc, Caen, France.
Elise DelaruePolyclinique du Parc, Caen, France.
Angélique DumontCentre Hospitalier Universitaire de Rouen Normandie, Rouen, France.
Samira BastiCentre de Lutte Contre Le Cancer Henri Becquerel, UNICANCER, Rouen, France.
Marianne HamonCentre de Lutte Contre Le Cancer François Baclesse, UNICANCER, 3 Avenue du Général Harris, 14000, Caen, France.
Laure KaluzinskiCentre Hospitalier Public du Cotentin, Cherbourg-en-Cotentin, France.
Lucie PottierCentre Hospitalier Public du Cotentin, Cherbourg-en-Cotentin, France.
Delphine DumontHôpital Privé de La Baie, Avranches, France.
Eddy FournierHôpital Privé de La Baie, Avranches, France.
Patricia BernardinCentre Hospitalier Eure-Seine, Evreux, France.
Tony CalacheCentre Hospitalier Eure-Seine, Evreux, France.
Guillaume BoudinCentre Hospitalier de Lisieux, Lisieux, France.
Helen HomokosHôpital Privé de L'Estuaire, Le Havre, France.
Albane CherelOMEDIT Normandie, Caen, France.
Cyril MagnanOMEDIT Normandie, Caen, France.
François FournelCentre Hospitalier Universitaire de Caen Normandie, Caen, France.
Alexandre MeurantCentre Hospitalier Universitaire de Caen Normandie, Caen, France.
Anais BriantCentre Hospitalier Universitaire de Caen Normandie, Caen, France.
Bérengère BeaupletCentre Hospitalier Universitaire de Caen Normandie, Caen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInternational guidelines published in 2022 recommend annual fall risk (FR) screening in adults aged ≥ 65 years. Older cancer patients are at increased risk of falls due to cancer-related symptoms, treatment toxicities, and concomitant medications. Falls may negatively impact cancer care and outcomes.

methodsThis exploratory multicenter cross-sectional and prospective study included patients aged ≥ 65 years treated for cancer in ten oncology ambulatory care units. Patients were recruited during World Patient Safety Day in September 2024. FR screening and preventive recommendations followed international guidelines. A 3-month follow-up assessed implementation in patients at high FR. The primary objective was to describe the prevalence of fallers and the distribution in the three FR levels in older adults with cancer. The secondary objectives were to identify factors associated with being at high FR and assess the feasibility of fall prevention recommendations.

resultsAmong 328 patients, 21% reported at least one fall in the previous year and 15% were classified as high FR. High FR was independently associated with older age (OR 1.33 per 5-year increase), taxane treatment (OR 3.74), and exposure to ≥ 2 fall-risk-increasing drugs (FRIDs) (OR 2.19). Polypharmacy was frequent (61%) but not associated with high FR. At 3 months, only 24% of high FR patients had fully implemented preventive recommendations, mainly biological assessments (60%), medication review (48%), and cardiovascular evaluation (43%).

conclusionHigh FR in older cancer patients is associated with potentially reversible pharmaceutical factors. Fall prevention recommendations remain poorly implemented, highlighting the need for structured multidisciplinary approaches. TRIAL REGISTRATION NUMBER: NCT06504628, registered on 2024-07-10.

Indexed as

Accidental FallsAntineoplastic AgentsNeoplasmsAgedAged, 80 and overAge FactorsCross-Sectional StudiesFemaleFranceHumansMalePractice Guidelines as TopicPrevalenceProspective StudiesRisk FactorsAntineoplastic AgentsAccidental fallsAntineoplastic agentsDrug-related side effects and adverse reactionsNeoplasmsOlder adultsPotentially inappropriate medication list

Identifiers

PMID42608484
PMCPMC13481749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.